NASDAQ:MBII
Delisted

Marrone Bio Innovations Stock News

etoro logo Buy MBII
*Your capital is at risk
$0.798
+0 (+0%)
At Close: Nov 04, 2022
Marrone (MBII) and Terramera are collaborating to bring technological and biological know-how to the market to enhance crop protection and create sustainable agricultural technologies.
Marrone Bio's (MBII) Q2 revenues were affected by severe drought in the western United States that led to reduced demand for insecticides and fungicides.
Marrone Bio Innovations' (MBII) CEO Kevin Helash on Q2 2021 Results - Earnings Call Transcript
Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of -100.00% and -28.38%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for t

Marrone Bio Innovations: Q2 Earnings Insights

05:19pm, Monday, 16'th Aug 2021
Shares of Marrone Bio Innovations (NASDAQ:MBII) fell 4.8% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 0.00% year over year to ($0.02),
DAVIS, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financi
Marrone Bio Innovations Inc (NASDAQ:MBII) (FRA:0MB) and partner Rizobacter have announced that Rizonema, a biological seed treatment for nematodes and soil-dwelling insects, will be offered for use in
Marrone's products are made from naturally-occurring substances like bacteria or plant extracts Biopesticides used in conjunction with chemical ones gives growers more control over pests The biopesti
Marrone Bio Innovations Inc (NASDAQ: MBII) has entered into a partnership with ATP Nutrition of Manitoba to distribute Stargus Biofungicide on Canadian broad-acre crops such as canola, dry beans, peas
Agreement Marks Expansion into the Broad Acre Crops Market Agreement Marks Expansion into the Broad Acre Crops Market
Marrone Bio Innovations' (MBII) CEO Kevin Helash on Q1 2021 Results - Earnings Call Transcript
Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of 0.00% and -0.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the
Marrone Bio Innovations Inc (NASDAQ) reported its 11th consecutive growth quarter with revenues increasing 14% year-over-year to $11 million. The Davis, California-based group attributed the revenue g

Marrone Bio Innovations Issues Shareholder Letter

04:10pm, Thursday, 13'th May 2021
DAVIS, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to
12:20pm: Pharmaceutical stocks fall The Dow was up 162 points, 0.5%, to 34,393 at midday. The Nasdaq was ticked down 7 points to 13,576, and the S&P 500 picked up 12 points, 0.3%, to 4,180.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE